Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 June 2005:
Vol. 308. no. 5730, pp. 1858 - 1860
DOI: 10.1126/science.308.5730.1858
Prev | Table of Contents | Next

News Focus

PHARMACOGENOMICS:
Going From Genome to Pill

Robert F. Service

A new medicine for African Americans with heart failure hints at what the drug industry sees as the enormous payoff from pharmacogenomics.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications.
D. Andes, A. Pascual, and O. Marchetti (2009)
Antimicrob. Agents Chemother. 53, 24-34
   Full Text »    PDF »
Exploiting race in drug development: BiDil's interim model of pharmacogenomics..
J. Kahn (2008)
Social Studies of Science 38, 737-758
   Abstract »    PDF »
Voriconazole therapeutic drug monitoring..
J. Smith, N. Safdar, V. Knasinski, W. Simmons, S. M. Bhavnani, P. G. Ambrose, and D. Andes (2006)
Antimicrob. Agents Chemother. 50, 1570-1572
   Abstract »    Full Text »    PDF »
What race and ethnicity measure in pharmacologic research..
J. M. Doyle (2006)
J. Clin. Pharmacol. 46, 401-404
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)